---

ICU Hypertension Management: Lines of Drugs

Key Principles

• There is no high-quality RCT evidence proving any single antihypertensive drug class reduces morbidity/mortality in hypertensive emergencies — trial quality is limited by small size, lack of blinding, and short follow-up.
• The therapeutic goal is to minimize target organ damage through rapid recognition and appropriate treatment.
• Continuous infusion of short-acting, titratable IV agents is preferred in the ICU to achieve rapid BP control while avoiding large swings.
• Drug selection must be individualized based on: pharmacology, underlying mechanism, degree of target organ damage, desired rate of BP decline, and comorbidities.

---

Target BP Reduction

Exception: Aortic dissection — reduce SBP to <120 mmHg within 20 minutes.

---

First-Line IV Agents (Titratable Infusions)

1. Clevidipine (Dihydropyridine CCB)

• Fastest onset among available agents; BP reduction faster than nicardipine.
• Half-life: ~1 minute; metabolized by plasma esterases (safe in renal/hepatic failure).
• Dose: Start 1–2 mg/hr, titrate every 90 seconds to 4–6 mg/hr (max 32 mg/hr).
• Best for: Perioperative hypertension, post-cardiac surgery, general ICU.
• Caution: Lipid emulsion vehicle — contraindicated in egg/soy allergy, severe lipid disorders.

2. Nicardipine (Dihydropyridine CCB)

• More effective than labetalol at reaching short-term BP targets (clinical trial evidence).
• Half-life: ~40 minutes; titratable continuous infusion.
• Dose: 5 mg/hr IV infusion; titrate by 2.5 mg/hr every 5–15 min (max 15 mg/hr).
• Best for: Hypertensive encephalopathy, neurological emergencies (stroke, SAH), eclampsia, post-op hypertension.
• Advantage: Does not reduce cerebral blood flow, unlike nitroprusside.

3. Labetalol (Mixed α/β-blocker)

• Can be given as IV bolus (20 mg q10 min) or continuous infusion (0.5–2 mg/min).
• Best for: Aortic dissection, hypertensive encephalopathy, eclampsia, cocaine-induced hypertension.
• Avoid in: Acute decompensated heart failure, severe bradycardia, reactive airway disease.

4. Esmolol (Ultra-short-acting β1-blocker)

• Half-life: ~9 minutes; ideal when HR control is also needed.
• Dose: Load 500–1000 mcg/kg, then infusion 50–300 mcg/kg/min.
• Best for: Aortic dissection (combined with vasodilator), perioperative tachycardia-hypertension.
• Avoid in: Heart block, severe LV dysfunction.

5. Sodium Nitroprusside (Direct vasodilator)

• Historically a "gold standard" but now used less due to serious risks.
• Onset: Seconds; offset: 1–10 minutes.
• Major concerns: Cyanide and thiocyanate toxicity (especially renal failure, prolonged use >24–48 hrs), coronary steal, reflex tachycardia, raised ICP.
• Still used in: Hypertensive crisis with acute pulmonary edema (short-term), when other agents unavailable.
• Requires arterial line monitoring and light protection of infusion.

6. Nitroglycerin (Nitrate vasodilator)

• Predominantly venodilator at low doses, arterial at higher doses.
• Best for: Hypertension with acute pulmonary edema or ACS/acute MI.
• Dose: 5–100 mcg/min IV infusion.
• Limitation: Tachyphylaxis within 24–48 hours; less reliable for isolated BP control.

7. Hydralazine (Direct arteriolar vasodilator)

• IV bolus 10–20 mg q4–6h; unpredictable onset and duration.
• Best for: Hypertension in pregnancy/eclampsia (well-studied, widely used).
• Avoid in: Aortic dissection, ischemic heart disease (reflex tachycardia).
• Not preferred in general ICU due to unpredictable pharmacokinetics.

8. Phentolamine (Alpha-adrenergic blocker)

• Specific niche: Catecholamine excess states — pheochromocytoma crisis, MAOI interactions, cocaine.
• Dose: 5 mg IV bolus.

---

Agent Selection by Clinical Scenario

---

Stepped Approach in the ICU

1. Establish arterial line for continuous beat-to-beat monitoring.
2. Identify target organ damage: Brain (encephalopathy, stroke), heart (ACS, dissection), kidneys, eyes.
3. Choose agent based on clinical scenario (table above).
4. Start continuous IV infusion (preferred over bolus for titratable control).
5. Avoid excessive hypotension — abrupt drops can precipitate ischemia (especially cerebral).
6. Transition to oral therapy within 24–48 hours once BP stabilized.

---

Key Takeaways from Recent Evidence

• Clevidipine > nicardipine for speed of BP reduction; both are superior to labetalol for reaching short-term targets (ACC/AHA Guidelines, p. 73).
• Nitroprusside use is declining due to cyanide toxicity risk and availability of safer alternatives.
• Aortic dissection still requires the most aggressive targets (SBP <120 mmHg within 20 minutes), best achieved with esmolol + nicardipine/nitroprusside combination.
• For neurological emergencies, nicardipine is preferred as it preserves cerebral autoregulation.
• In stroke without thrombolysis, BP is often permissively allowed up to 220/120 mmHg to preserve perfusion.

---